Načítá se...
Ephedrine for myasthenia gravis, neonatal myasthenia and the congenital myasthenic syndromes
BACKGROUND: Myasthenia is a condition in which neuromuscular transmission is affected by antibodies against neuromuscular junction components (autoimmune myasthenia gravis, MG; and neonatal myasthenia gravis, NMG) or by defects in genes for neuromuscular junction proteins (congenital myasthenic synd...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2014
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7387729/ https://ncbi.nlm.nih.gov/pubmed/25515947 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD010028.pub2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|